Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Invitation - Presentation of Financial Results for Q3 2013

Det norske oljeselskap ASA ("DETNOR") will present its financial results for the third quarter 2013 on Friday November 1st, 2013.The venue is Hotel Continental in Oslo (Stortingsgaten 24/26) at 08:15 a.m. (CET). Please submit your registration to detnor@detnor.no by 12:00 (noon), October 31. A live webcast of the interim results will be available on www.detnor.no . Contact:Knut Evensen, VP Investor Relations, tel.: +47 950 77 622

Build a Better Business

News release 10th October 2013A free business advice event to be staged in Lincoln next month will point firms towards a more prosperous and sustainable future. Building a Better Business returns by popular demand with a range of speakers covering topics as diverse as PR, email marketing, employment law, profit improvement and customer service. Organised by Lincolnshire Chamber of Commerce in conjunction with accountancy firm Streets Chartered Accountants and Lincolnshire County Council, the event at The Showroom in Lincoln on Wednesday 20th November aims to equip Lincolnshire

Addnode Group's Nomination Committee

STOCKHOLM, October 10, 2013 - In accordance with the decision of Addnode Group Meeting May 7, 2013, it is hereby announced that the three largest shareholders' representatives and a representative of institutional shareholders and one for the small shareholders, who together with the Chairman of the Board will comprise the Nomination Committee until the new Nomination Committee is appointed by the next Annual General Meeting.- Vidinova AB, represented by Wilhelm Arnör, Committee Chairman as the representative of the largest shareholder- Aretro Capital AB, represented by Jonas Gejer-

Axis introduces a fully featured, bullet-style outdoor-ready network camera

The bullet-style AXIS Q1765-LE Network Camera offers full HD image quality, 18x optical zoom and built-in IR illumination making it ideal for around-the-clock surveillance installations, where it covers great distances providing both wide overviews as well as detailed images for identification purposes. The outdoor-ready AXIS Q1765-LE is designed for monitoring entrances, exits and perimeter, and for pole mounting for surveillance of parking lots or general city surveillance purposes.Axis Communications, the world leader in network video, today presents a strong addition to its line of

SKF’s nine-month results will be published on 15 October, 2013

Gothenburg, 10 October 2013: The SKF Group will publish their third-quarter results on 15 October, 2013 and invites investors, analysts and the media to take part in the conference call. It will be held in English, at 13.00 (CEST), 12.00 (UK) 07.00 a.m. (US Eastern Standard Time). The following SKF executives will be present:Tom Johnstone, President and CEOHenrik Lange, Executive Vice President and CFOIngalill Östman, Senior Vice President, Group CommunicationsMarita Björk, Head of Investor Relations. Telephone Genesys Conferencing:SE: +46 (0)8 506 307 79UK: +44 (0)844 571

31 January deadline for UTC Swindon applications draws closer

UTC Swindon is reminding prospective students that the deadline to apply for places is Friday 31 January 2014. Angela Barker-Dench, Principal at the new University Technical College which opens in September 2014, said, “We have seen enormous interest from potential students and have received many applications already. We strongly urge pupils interested in becoming part of our first intake to apply now.” Online applications can be submitted at www.utcswindon.co.uk/admissions-and-applications/make-an-application/. Alternatively, call UTC Swindon on 07990 601 516 or email info@utcswindon.

Kværner ASA: Minutes of Kværner ASA's Extraordinary General Meeting 2013

10 October 2013 - The Extraordinary General Meeting of Kværner ASA was held on Thursday, 10 October 2013 at Drammensveien 264, Oslo, Norway. All proposals on the agenda were adopted; cf. the notice of the Extraordinary General Meeting that was published to the Oslo Børs on 18 September 2013. The Extraordinary General Meeting approved the Board of Directors' proposal to distribute a semi-annual dividend of NOK 0.58 per share. The dividend will be paid on or about 24 October 2013 to shareholders of record as of the date of the Extraordinary General Meeting. The shares will be traded ex-

Institut Paoli-Calmettes becomes first RayStation® reference clinic in France

RaySearch Laboratories AB has received an order for its RayStation® treatment planning system from Institut Paoli-Calmettes (IPC) in Marseille, France.IPC is a French regional comprehensive cancer center that serves the Provence-Alpes-Côte d’Azur and Corsica region. The center offers all forms of cancer therapy and is also conducting extensive research programs. The hospital has over 1,300 employees and treats around 7,000 new cancer patients annually. IPC will use RayStation® as its treatment planning system for conventional 3D-CRT treatments, as well as more advanced treatments, such as

Read original

Invitation – third quarter results presentation

Husqvarna’s interim report for the third quarter 2013 will be published around 08:00 CET on October 24. The report and conference call slides will be available at www.husqvarnagroup.com/ir. Results presentation, conference call and audio cast at 10:00 CETFinancial analysts and media are invited to a presentation of the results at 10:00 CET the same day, hosted by Kai Wärn, President & CEO and Ulf Liljedahl, CFO. The presentation will be held at Husqvarna’s office in Stockholm on Regeringsgatan 28. Dial in details and audio web castTo participate by phone, dial +46 (0) 8 5052 0110 (

Lundbeck and Otsuka initiate phase III clinical trials on Lu AE58054 as a new add-on treatment for Alzheimer’s disease

· The clinical program in Alzheimer’s disease is planned to include approximately 3,000 patients from several countries worldwide · Lu AE58054 is a selective 5-HT6 receptor antagonist under investigation for the treatment of Alzheimer's disease[i]  · The focus of the two companies on the 5-HT6 receptor is a different approach from much of drug research to date on Alzheimer’s disease · Alzheimer's disease affects more than 26 million people worldwide[ii] 

CORRECTION: Aker Solutions to Lease New Office Building in Fornebu

This is a correction of the announcement from 08:00 10.10.2013 CEST. Reason for the correction: Ownership holding in final paragraph. 10 October 2013 - Aker Solutions agreed today to lease a building in Fornebu for an initial 12 years, starting in 2016, to expand its office space capacity near Oslo. The property is under construction and will contain about 32,000 square meters of office and common-area space on completion. Aker Solutions already has long-term leases for two nearby office buildings, including its main office. The company may extend the rental period for the new

Javelin Capital Markets selects Cinnober for SEF trading platform surveillance

Swap-trading marketplace Javelin — which recently received provisional regulatory approval to operate as a swap execution facility (SEF) — has strengthened its trading platform with the integration of Scila Surveillance from independent technology supplier Cinnober. The Scila surveillance system enforces market integrity as required by the Dodd-Frank Act 2010. “Our priority is to implement a market surveillance system that not only meets the monitoring requirements of the SEF new regulations, but also exceeds Javelin’s own internal expectations of high levels of trading integrity to

Volvo truck chased by bulls

Volvo Trucks is now launching yet another film in its series of spectacular tests. In the latest film, ‘The Chase’, precision driver Rob Hunt, renowned from his roles in major Hollywood productions, plays a starring role. His mission is to drive the Volvo FL distribution truck in a race in the medieval Spanish town of Ciudad Rodrigo – chased by several tonnes of bulls.In ‘The Chase’ Volvo Trucks aimed to show how easy it is to manoeuvre the new 12-tonne truck in a demanding urban environment. “The city is old, the streets are narrow and we drive on slippery cobblestones. To be chased by

Invitation to presentation of Eniro´s interim report, January–September 2013

Eniro’s interim report for the third quarter 2013 will be published at 08:00 CET on October 23rd 2013. A web-cast telephone conference will be held at 10:00 CET the same day. Eniro’s President and CEO Johan Lindgren and Eniro’s CFO Mattias Lundqvist will present the results for the third quarter and answer questions. A possibility will be given to ask questions via the webcast and follow the presentation material live. The webcast is available on demand. To participate in the conference call, and thereby be able to ask questions, please call one of the following numbers: SE: +46 (0) 8

Veidekke ASA : Veidekke enters housing project in Gothenburg

Veidekke will take part in the development of the Nya Hovås area in Gothenburg. Through the agreement, Veidekke will acquire one third of the project and expect a turnover of approximately 1 billion NOK. A total of 1,200 apartments and 25,000 square meters are planned in the project Nya Hovås. Veidekke's partners in this extensive project are Skanska and HSB Gothenburg. The project is a result of an open dialogue with the business community, neighbours and other interested parties. Based on more than 8,000 received proposals, a detailed plan has been prepared for the area. "We are

Financial Statement 12/13

September 2012 – August 2013Diamyd Medical AB (publ), former Diamyd Therapeutics ABFiscal year 2012/2013Reporting period, June 1, 2013 – August 31, 2013 · Net sales amounted to MSEK 0.1 (0) · Loss before tax amounted to MSEK -4.3 (-4.2) · Liquid assets amounted to MSEK 65.5 (22.0) as of August 31, 2013 Full year, September 1, 2012 – August 31, 2013 · Net sales amounted to MSEK 0.1 (0.5) · Loss before tax amounted to MSEK -12.6 (-16.3) Significant events during the reporting periodJune 1, 2013 – August 31, 2013 · Diamyd Medical’s rights issue was

MIV-247 has been selected as a candidate drug and enters development for the treatment of neuropathic pain

Stockholm, Sweden – Medivir AB (OMX:MVIR) announced that MIV-247 has been selected as a candidate drug (CD) from its cathepsin S inhibitor project for the treatment of neuropathic pain, and is entering non-clinical development. Approximately 25 million patients across the US, Europe and Japan suffer from neuropathic pain, which includes diabetic neuropathy, post-herpetic neuralgia and neuropathic low-back pain. Currently marketed drugs have limited efficacy and poor side-effect profiles. Patients with neuropathic pain are therefore in great need of new and efficacious therapies that can

Aker ASA: Fornebuporten enters lease agreement with Aker Solutions for new office building

10 October 2013 - Fornebuporten AS, a subsidiary of Aker ASA, has entered a long-term lease agreement with Aker Solutions ASA starting in 2016 for offices to be built in Fornebu, near Oslo.The barehouse contract is for approximately 32,000 square meters of office and common space, and for a duration of 12 years, with two additional five-year options. The building is scheduled for completion in June 2016. For further details, reference is made to Aker Solutions stock exchange notice published today. END For further information, please contact: Investors:Marianne Stigset,

HALFORDS DEVELOPS ‘DASH-CAM’ RANGE IN RESPONSE TO MOTORISTS CONCERNS OVER CRASH FOR CASH CLAIMS

Halfords is introducing new in-car cameras designed to film vehicle journeys and capture events before, during and after a collision to help drivers resolve insurance claims. The devices - known as ‘dash-cams’ - record the view through the windscreen in real time and are becoming increasingly popular among motorists who want to protect themselves against fraudsters. Halfords in-car technology manager Alec James said: “Following an incident people are often reluctant to admit guilt and risk losing their no claims discount*. In addition, the surge in fraudulent so-called ‘crash for cash’

MOTORISTS INSTALL CAMERAS TO COMBAT CRASH FOR CASH CLAIMS

Motorists are installing video cameras in their cars to combat ‘crash for cash’ fraud claims. The devices, known as ‘dash-cams, record the view through the windscreen and capture events before, during and after a collision. The recorded footage can also be used by defendants against accusations of lane-hogging or tailgating on motorways following new fixed penalty legislation which came into force in August.‎ Halfords is introducing new in-car camera products in response to this growing demand - making the technology that has been widely used by the emergency services for many

DiaGenic provides study results and update on key clinical programs

DiaGenic announces results from the calibration study for MCItect®, a blood based diagnostic test for Alzheimer’s disease in the pre-dementia stage. In a patient population of 157 patients diagnosed with amnestic mild cognitive impairment, MCItect® demonstrated a total prediction accuracy of 75% in detecting patients converting to Alzheimer’s disease dementia within two years.The study included 157 patients from 19 centers in Europe and the U.S. diagnosed with amnestic mild cognitive impairment, MCI, that either remained stable or progressed to Alzheimer’s disease dementia during a two-year

TOMRA: INVITATION TO 3Q 2013 PRESENTATION

TOMRA's third quarter 2013 results will be released Thursday 17th of October 2013. President & CEO Stefan Ranstrand will present the results at 08:00 CET. The presentation will be held in English and take place at Thon Conference Vika Atrium (Meetingroom: Nyland). A live broadcast of the presentation will be available on www.tomra.com, and the recorded version of the presentation will be available after the broadcast has concluded. The written materials will be made available from 07:30 CET on www.tomra.com (Investor Relations section) and at the place of venue. Asker, 10 October

Pergamum announces final data from Phase I/II study of LL-37 in patients with chronic leg ulcers

STOCKHOLM – October 10, 2013. Pergamum AB, which is a portfolio company of Karolinska Development AB, announced today that it has finalized the Clinical Study Report of a randomized Phase I/II trial of LL-37 for treatment of venous leg ulcers. Patients treated with LL-37 had a statistically significant improved healing rate compared with placebo and no safety or tolerability concerns were noted, confirming the positive preliminary data reported in July this year.Chronic leg ulcers are often defined as those that fail to heal after six weeks or more of appropriate treatment. Venous leg

There are no items matching the current filter
There are no more items matching the current filter
Back to top